Conditinal Approval List of articles

ELIQUENT Japan > Conditinal Approval

2026.01.21

Holograms,of,capsule;,charts,and,dna,helix,on,scientific,backdrop.

Japan Advances Regulatory Reforms on RWD Utilization, Conditional Approval, and Pediatric Drug Development

Introduction to Regulatory Revisions According to the notification issued by Japan’s Ministry of Health, Labou […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
 Phone:+81-3-6304-5570